Veterinary Medicines Information website

EURICAN DAPPi - L liofilizat in suspenzija za pripravo suspenzije za injiciranje za pse

Authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Download as PDF

Product identification

Medicine name:
EURICAN DAPPi - L liofilizat in suspenzija za pripravo suspenzije za injiciranje za pse
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Canine parainfluenza virus, Live
  • Canine parvovirus, Live
  • Canine adenovirus 2, Live
  • Canine distemper virus, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
    1.00
    European Pharmacopoeia Unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, Inactivated
    1.00
    European Pharmacopoeia Unit(s)
    /
    1.00
    Dose
  • Canine parainfluenza virus, Live
    50118.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, Live
    79432.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, Live
    316.20
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, Live
    10000.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0125/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 14/11/2021
Updated on: 14/03/2026
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 14/11/2021
Updated on: 14/03/2026
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 14/11/2021
Updated on: 14/03/2026
Download